We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Finding on Chromosomes

By Biotechdaily staff writers
Posted on 01 Aug 2005
Mammalian chromosomes evolve by breaking at specific sites rather than randomly as long thought, according to a new study published in the July 22, 2005, issue of Science.

An international team of scientists from France, Singapore, and the United States compared the organization of the chromosomes of eight mammalian species: human, mouse, rat, cow, pig, dog, cat, and horse. More...
Using computer software to align and compare the mammals' genetic material, the team determined that chromosomes tend to break in the same places as species evolve, resulting in rearrangements of their DNA. Before this, the prevailing view was that such rearrangements occurred at random locations.

Chromosomal breakages, also called translocations, are important in terms of evolution. When they break in egg or sperm cells, opportunities arise for the rearrangement of DNA in the resulting offspring. Such inheritable rearrangements may be lethal or cause disease. However, in some cases, the breaks can lead to the production of new or altered proteins with the potential to benefit an organism. In addition, chromosomal translocations are known to contribute to the development or progression of many types of cancer.

The researchers noted that the chromosomal abnormalities most frequently associated with human cancer are far more likely to occur in or near the evolutionary breakage hotspots than are less-common types of cancer-associated abnormalities. They speculate that the rearrangements seen near breakage hotspots may activate genes that trigger cancer and/or genes that normally suppress cancer. One finding was that the regions immediately flanking the breakage hotspots contain more genes, on average, than the rest of the genome. Another finding was that the rate of chromosomal evolution among mammals dramatically accelerated following the extinction of the dinosaurs about 65 million years ago.

The research team, which included investigators from the U.S. National Human Genome Research Institute (NHGRI, Bethesda, MD, USA), was led by Harris A. Lewin, Ph.D., of the University of Illinois at Urbana-Champaign (USA) and William J. Murphy, Ph.D., of Texas A&M University in College Station (USA).

"The dog genome map generated by NHGRI researchers and their collaborators played a key role in these new analyses,” observed Eric D. Green, M.D., Ph.D., scientific director of NHGRI. "This study shows the tremendous power of using multi-species genome comparisons to understand evolutionary processes, including those with potential relevance to human disease.”





Related Links:
NHGRI

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.